INC Research to acquire inVentiv Health in $4.6B deal
May 11, 2017
Practice Management | Boston, MA | Corporate Acquisition
INC Research (NASDAQ: INCR) has agreed to pick up fellow contract medical research company inVentiv Health in an all-stock transaction that values inVentiv at approximately $4.6 billion. The deal will create a combined company with an enterprise value of approximately $7.4 billion. PE firms Advent International and Thomas H. Lee Partners currently hold a combined stake of 47% in inVentiv and will remain investors. INC Research's shares closed up 21% Wednesday at $52.80 apiece.